Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study
Open accessThe DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
AIM: The aim of this study was to assess the prevalence and patterns of exposure to antidepressants before, during and after pregnancy in a cohort including all pregnant women in Denmark between 1997 and 2010. METHODS: We performed a retrospective cohort study including 912 322 pregnancies. Information was retrieved from the Danish Birth Registry and The Register of Medicinal Product Statistics to identify women redeeming an antidepressant prescription during pregnancy. Exposure periods were based on standard treatment doses and dispensed pack sizes. RESULTS: We identified 19 740 pregnancies exposed to an antidepressant at some point during pregnancy. The rate of exposure increased from 0.2% in 1997 to 3.2% in 2010. We found that the rate of exposure was halved during the first 3 months of pregnancy. In contrast, we describe a clear increase in exposure after pregnancy among pre-delivery treatment-naïve women. CONCLUSIONS: In spite of uncertainty concerning antidepressants' safety during pregnancy we find a 16-fold increase in exposure rates between 1997 and 2010. The rates describe a sharp decrease in exposure during pregnancy that is probably caused by physicians' hesitation to prescribe antidepressants and women's fear of unwanted effects on the unborn child. More studies are needed to clarify the consequences of antidepressant discontinuation during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“It is estimated that approximately 20% of women of childbearing age (25–45 years), [1,2] and up to 15% of pregnant women suffer from depressive symptoms [3,4].”
Background(2016) · Repository@Hull (Worktribe) (University of Hull) · doi:10.1111/j.1365 · Cited by 5,304
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725 · cited 1×
“It is estimated that approximately 20% of women of childbearing age (25–45 years), [1,2] and up to 15% of pregnant women suffer from depressive symptoms [3,4].”
BackgroundThe Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
Offspring of Depressed Parents: 20 Years Later
Weissman, M. M., Wickramaratne, P., Nomura, Y., Warner, V., Pilowsky, D., & Verdeli, H. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.1001 · Cited by 1,059
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
The Danish prescription registries.
Gaist, D., Sørensen, H. T., & Hallas, J. (1997) · PubMed · Cited by 570
Women’s Attitudes, Preferences, and Perceived Barriers to Treatment for Perinatal Depression
Goodman, J. H. (2009) · Birth · doi:10.1111/j.1523-536x.2008.00296.x · Cited by 526 · cited 1×
“On the other hand, in spite of doctor recommendation, only 35% of pregnant women reported to be willing to take antidepressants during pregnancy in an American study [52].”
BackgroundPerinatal Risks of Untreated Depression during Pregnancy
Bonari, L., Pinto, N., Ahn, E., Einarson, A., Steiner, M., & Koren, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901103 · Cited by 524 · cited 1×
“Depression during pregnancy is associated with preterm delivery, low birth weight, epidural analgesia, caesarean section, intensive ward admission, and disturbances in the child’s neurocognitive and socioemotional development [4–8].”
BackgroundAntepartum Depressive Symptomatology Is Associated With Adverse Obstetric and Neonatal Outcomes
Chung, T. K. H., Lau, T. K., Yip, A. S. K., Chiu, H. F. K., & Lee, D. T. S. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200109000-00017 · Cited by 501
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Louik, C., Lin, A. E., Werler, M. M., Hernández-Díaz, S., & Mitchell, A. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067407 · Cited by 500
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Increasing use of antidepressants in pregnancy
Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.01.033 · Cited by 458
Kulin, N. A., Pastuszak, A., Sage, S. R., Schick-Boschetto, B., Spivey, G., Feldkamp, M., Ormond, K., Matsui, D., Stein-Schechman, A. K., Cook, L., et al. (1998) · JAMA · doi:10.1001/jama.279.8.609 · Cited by 424 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultUse of antidepressant medications during pregnancy: a multisite study
Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S. J., Roblin, D., Smith, D. H., Willy, M. E., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.036 · Cited by 403 · cited 2×
“Exposure Rates, 1997–2010 The increase in prevalence over the years is comparable to studies from other countries, although our estimates are considerably lower [44–49].”
ResultOutcomes of Prenatal Antidepressant Exposure
Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2055 · Cited by 386 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultRecall Accuracy for Prescription Medications: Self-report Compared with Database Information
West, S. L., Savitz, D. A., Koch, G., Strom, B. L., Guess, H. A., & Hartzema, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117563 · Cited by 352 · cited 1×
“This information is difficult to obtain through questionnaires or interviews of women who have to remember use of medications over a long period of time [65– 68].”
BackgroundReis, M., & Källén, B. (2010) · Psychological Medicine · doi:10.1017/s0033291709992194 · Cited by 340 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultRELIABILITY OF RECALL OF DRUG USAGE AND OTHER HEALTH-RELATED INFORMATION1
HILL, A. P., & ROSS, R. K. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113386 · Cited by 315
Pedersen, L. H., Henriksen, T. B., Vestergaard, M., Olsen, J., & Bech, B. H. (2009) · BMJ · doi:10.1136/bmj.b3569 · Cited by 297 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultDelivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B., & Wiholm, B.-E. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultPreferences and perceived barriers to treatment for depression during the perinatal period
O'Mahen, H. A., & Flynn, H. A. (2008) · Journal of Women s Health · doi:10.1089/jwh.2007.0631 · Cited by 277
Kieler, H., Artama, M., Engeland, A., Ericsson, O., Furu, K., Gissler, M., Nielsen, R. B., Norgaard, M., Stephansson, O., Valdimarsdottir, U., et al. (2011) · BMJ · doi:10.1136/bmj.d8012 · Cited by 277 · cited 1×
“On the other hand, studies show a clear association between SSRI use and persistent pulmonary hypertension of the newborn [35], and no association with perinatal mortality [36,37].”
BackgroundBérard, A., Ramos, É., Rey, É., Blais, L., St.‐André, M., & Oraichi, D. (2007) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20099 · Cited by 275 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultGrigoriadis, S., & Robinson, G. E. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653294 · Cited by 272 · cited 1×
“It is estimated that approximately 20% of women of childbearing age (25–45 years), [1,2] and up to 15% of pregnant women suffer from depressive symptoms [3,4].”
BackgroundKällén, B. A. J., & Otterblad Olausson, P. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20327 · Cited by 270 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultEinarson, A., Selby, P. L., & Koren, G. (2001) · PubMed · Cited by 244
Selective serotonin reuptake inhibitors and adverse pregnancy outcomes
Wen, S. W., Yang, Q., Garner, P., Fraser, W., Olatunbosun, O., Nimrod, C., & Walker, M. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.02.019 · Cited by 234 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultOffspring of Depressed Parents: 20 Years Later
Weissman, M. M. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.6.1001 · Cited by 214
Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
Malm, H., Artama, M., Gissler, M., & Ritvanen, A. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318220edcc · Cited by 213
Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
Malm, H., Klaukka, T., & Neuvonen, P. J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187302.61812.53 · Cited by 211 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultParoxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study
Diav‐Citrin, O., Shechtman, S., Weinbaum, D., Wajnberg, R., Avgil, M., Di Gianantonio, E., Clementi, M., Weber‐Schoendorfer, C., Schaefer, C., & Ornoy, A. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03261.x · Cited by 207
Davis, R. L., Rubanowice, D., McPhillips, H., Raebel, M. A., Andrade, S. E., Smith, D., Yood, M. U., & Platt, R. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1462 · Cited by 203 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultPetersen, I., Gilbert, R. E., Evans, S. J. W., Man, S.-L., & Nazareth, I. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06090blu · Cited by 192 · cited 1×
“3% in 2006, based on data from general practices [49].”
BackgroundOberlander, T. F., Warburton, W., Misri, S., Riggs, W., Aghajanian, J., & Hertzman, C. (2008) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20144 · Cited by 187 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultA COMPARISON OF PREGNANCY HISTORY RECALL AND MEDICAL RECORDS
TILLEY, B. C., BARNES, A. B., BERGSTRALH, E., LABARTHE, D., NOLLER, K. L., COLTON, T., & ADAM, E. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113997 · Cited by 187
Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P. B., Lipworth, L., & Sørensen, H. T. (2006) · Epidemiology · doi:10.1097/01.ede.0000239581.76793.ae · Cited by 185
Do Pregnant Women Report Use of Dispensed Medications?
Olesen, C., Søndergaard, C., Thrane, N., Lauge Nielsen, G., de Jong-van den Berg, L., & Olsen, J. (2001) · Epidemiology · doi:10.1097/00001648-200109000-00006 · Cited by 179 · cited 1×
“A small Danish study estimated that compliance in Denmark is 80% for antidepressant treatment during pregnancy [64].”
BackgroundPrevalence and patterns of antidepressant drug use during pregnancy
Ververs, T., Kaasenbrood, H., Visser, G., Schobben, F., de Jong-van den Berg, L., & Egberts, T. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0177-0 · Cited by 174 · cited 1×
“Exposure Rates, 1997–2010 The increase in prevalence over the years is comparable to studies from other countries, although our estimates are considerably lower [44–49].”
ResultFurther Development of the Postpartum Depression Predictors Inventory‐Revised
Beck, C. T., Records, K., & Rice, M. J. (2006) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2006.00094.x · Cited by 168 · cited 1×
“Untreated depression during pregnancy is associated with a 6-fold risk increase of postpartum depression [4,9].”
BackgroundEinarson, A., Choi, J., Einarson, T. R., & Koren, G. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400405 · Cited by 163 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultParoxetine in the first trimester and the prevalence of congenital malformations
Cole, J. A., Ephross, S. A., Cosmatos, I. S., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1463 · Cited by 162
Wurst, K. E., Poole, C., Ephross, S. A., & Olshan, A. F. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20627 · Cited by 159
Bakker, M. K., Kölling, P., Van Den Berg, P. B., De Walle, H. E. K., & De Jong van den Berg, L. T. W. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03048.x · Cited by 158
Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy
Wichman, C. L., Moore, K. M., Lang, T. R., Sauver, J. L. S., Heise, R. H., & Watson, W. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.1.23 · Cited by 157
Patterns of antidepressant medication use among pregnant women in a United States population
Alwan, S., Reefhuis, J., Rasmussen, S. A., Friedman, J. M., & Study, N. B. D. P. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010373928 · Cited by 149
Antidepressant drugs during pregnancy and infant congenital heart defect
Källén, B. A. J., & Olausson, P. O. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.11.006 · Cited by 149 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultJimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Jensen, J. K., Afzal, S., Gislason, G. H., Torp-Pedersen, C., & Poulsen, H. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001148 · Cited by 139 · cited 2×
“We have previously used this method to calculate treatment periods during pregnancy [34,36].”
MethodResultSelf-citationDelivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants
Lennestål, R., & Källén, B. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4d2 · Cited by 129 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultNew indications for antidepressants.
Schatzberg, A. F. (2000) · PubMed · Cited by 123
Comparison of questionnaire information and pharmacy data on drug use
van den Brandt, P. A., Petri, H., Dorant, E., Goldbohm, R. A., & de Crommert, S. V. (1991) · Pharmacy World & Science · doi:10.1007/bf01974987 · Cited by 120
Bakker, M. K., Kerstjens‐Frederikse, W. S., Buys, C. H. C. M., de Walle, H. E. K., & de Jong‐van den Berg, L. T. W. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20641 · Cited by 117
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
Stephansson, O., Kieler, H., Haglund, B., Artama, M., Engeland, A., Furu, K., Gissler, M., Nørgaard, M., Nielsen, R. B., Zoega, H., et al. (2013) · JAMA · doi:10.1001/jama.2012.153812 · Cited by 101 · cited 1×
“On the other hand, studies show a clear association between SSRI use and persistent pulmonary hypertension of the newborn [35], and no association with perinatal mortality [36,37].”
BackgroundThe Danish Fertility Database.
Lb, K. (1998) · PubMed · Cited by 100
Prevalence and predictors of antidepressant use in a cohort of pregnant women
Ramos, É., Oraichi, D., Rey, É., Blais, L., & Bérard, A. (2007) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01387.x · Cited by 95 · cited 1×
“Approximately half of all pregnancies discontinued treatment during pregnancy, which is in accordance with previously published literature [46,49,54–57].”
ResultDuration of antidepressant use during pregnancy and risk of major congenital malformations
Ramos, É., St-André, M., Rey, É., Oraichi, D., & Bérard, A. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042523 · Cited by 89 · cited 1×
“However, the results are conflicting [12,14,17–19,23–33] and studies including up to a million pregnancies indicate little risk of congenital malformations [12], [17,19,31,32], or the possibility of confounding by indication [34].”
ResultCohen, L. S., Nonacs, R. M., Bailey, J. W., Viguera, A. C., Reminick, A. M., Altshuler, L. L., Stowe, Z. N., & Faraone, S. V. (2004) · Archives of Women s Mental Health · doi:10.1007/s00737-004-0059-3 · Cited by 82 · cited 1×
“Pregnancy does not seem to protect against the risk of depression relapse [59].”
BackgroundSelective Serotonin-Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn
(2006) · New England Journal of Medicine · doi:10.1056/nejmc060602 · Cited by 61
La dépression de l’antepartum : prévalence, diagnostic, traitement
Chatillon, O., & EVEN, C. (2010) · L Encéphale · doi:10.1016/j.encep.2010.02.004 · Cited by 61
SSRI Use During Pregnancy and Risk of Stillbirth and Neonatal Mortality
Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Lander, A. R., Afzal, S., Torp-Pedersen, C., & Poulsen, H. E. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081251 · Cited by 60 · cited 2×
“We have previously used this method to calculate treatment periods during pregnancy [34,36].”
BackgroundMethodSelf-citationMunk‐Olsen, T., Gasse, C., & Laursen, T. M. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01784.x · Cited by 48 · cited 1×
“Approximately half of all pregnancies discontinued treatment during pregnancy, which is in accordance with previously published literature [46,49,54–57].”
ResultRemission of maternal depression and child symptoms among single mothers: A STAR*D-Child report
Talati, A., WICKRAMARATNE, P. J., Pilowsky, D. J., Alpert, J. E., Cerda, G., Garber, J., Hughes, C. W., King, C. A., Malloy, E., Sood, A. B., et al. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-007-0262-4 · Cited by 45 · cited 1×
“Depression during pregnancy is associated with preterm delivery, low birth weight, epidural analgesia, caesarean section, intensive ward admission, and disturbances in the child’s neurocognitive and socioemotional development [4–8].”
BackgroundSørensen, H. T., Hansen, I. T., Ejlersen, E., Sabroe, S., & Hamburger, H. J. (1996) · Journal of Medical Systems · doi:10.1007/bf02260874 · Cited by 37 · cited 2×
“This ensures high rates of registration [42].”
BackgroundRecent Trends in Selective Serotonin Reuptake Inhibitor Use in Pregnancy
Wichman, C. L., Fothergill, A., Moore, K. M., Lang, T. R., Heise, R. H., & Watson, W. J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818b53fd · Cited by 34 · cited 1×
“Exposure Rates, 1997–2010 The increase in prevalence over the years is comparable to studies from other countries, although our estimates are considerably lower [44–49].”
ResultEstimating the Economic Costs of Antidepressant Discontinuation during Pregnancy
O'Brien, L., Laporte, A., & Koren, G. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400607 · Cited by 17
Do therapeutic indications of antidepressants change from one year to another?
Cuevas, C. D. L., & Sanz, E. J. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.891 · Cited by 15
Awareness of folic acid for neural tube defect prevention among Israeli women
Ringel, S., Lahat, E., Elizov, T., Greenberg, R., Arieli, S., Afriat, R., & Berkovitch, M. (1999) · Teratology · doi:10.1002/(sici)1096-9926(199907)60:1<33::aid-tera9>3.0.co;2-x · Cited by 14
Einarson, A., Choi, J., Einarson, T. R., & Koren, G. (2008) · Value in Health · doi:10.1016/s1098-3015(10)66425-x · Cited by 2
Cited by
Clinical management of perinatal anxiety disorders: A systematic review
Marchesi, C., Ossola, P., Amerio, A., Daniel, B. D., Tonna, M., & De Panfilis, C. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.004 · Cited by 169
O'Connor, T. G., Monk, C., & Fitelson, E. M. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12153 · Cited by 130
“…maternal anxiety, stress, and depression is particularly problematic given resistance to medication in certain subgroups in particular (see, Jimenez-Solem et al., 2013; Kozhimannil, Adams, Soumerai, Busch, & Huskamp, 2011) and the suggestion that SSRIs may have adverse effects on the…”
BackgroundGao, S.-Y., Wu, Q.-J., Sun, C., Zhang, T.-N., Shen, Z.-Q., Liu, C.-X., Gong, T.-T., Xu, X., Ji, C., Huang, D.-H., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1193-5 · Cited by 152
Zoega, H., Kieler, H., Nørgaard, M., Furu, K., Valdimarsdottir, U., Brandt, L., & Haglund, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144474 · Cited by 108
“Many, but not all [3], previous studies of the utilization and discontinuation of these antidepressants during pregnancy are based on self-reported surveys [4, 23, 24], insurance or reimbursement data [7, 6, 8, 17], or local pharmacy-dispensing data [25], potentially limiting the internal and external validity of the…”
BackgroundResultInfluentialPerinatal psychiatric episodes: a population-based study on treatment incidence and prevalence
Munk-Olsen, T., Maegbaek, M. L., Johannsen, B. M., Liu, X., Howard, L. M., di Florio, A., Bergink, V, & Meltzer-Brody, S. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.190 · Cited by 103
Metadata
- Authors
- Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Andersen, N. L., Torp-Pedersen, C., & Poulsen, H. E.
- Affiliations
- Bispebjerg Hospital (DK)
- Copenhagen University Hospital (DK)
- University of Copenhagen (DK)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-25
- Volume
- 8
- Issue
- 4
- Pages
- e63034
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3636192
- OpenAlex
- W2158461066
- Cited by
- 119
- References
- 68
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 15 · 2019: 16 · 2018: 11 · 2017: 7 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 1
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Forsknings- og Innovationsstyrelsen
- Danish Agency for Science and Higher Education
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- antidepressants, pregnancy, antidepressant exposure, prevalence, maternal mental health, antidepressant discontinuation, postpartum depression, prescribing patterns, drug safety in pregnancy, Denmark
- MeSH terms
- Adult, Antidepressive Agents, Denmark, Female, Humans, Pregnancy, Public Health, Time Factors, Cohort Studies, Prevalence, Maternal Exposure, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.